PAPER Miloyan BH, Razani J, Larco A, Avila J, Chung J
SEARCH RESULTS
331259 RESULTS
PAPER Gu L, Guo Z
Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
J Neurochem. 2013 Feb 14; PubMed: 23406382PAPER van Bebber F, Hruscha A, Willem M, Schmid B, Haass C
Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes.
J Neurochem. 2013 Feb 14; PubMed: 23406323PAPER Shi JQ, Zhang CC, Sun XL, Cheng XX, Wang JB, Zhang YD, Xu J, Zou HQ
Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activation.
CNS Neurosci Ther. 2013 Apr;19(4):262-8. PubMed: 23406388PAPER Hori T, Sanjo N, Tomita M, Mizusawa H
Visual reproduction on the wechsler memory scale-revised as a predictor of Alzheimer's disease in Japanese patients with mild cognitive impairments.
Dement Geriatr Cogn Disord. 2013;35(3-4):165-76. PubMed: 23406667PAPER Van Vlaslaer A, Mortishire-Smith RJ, Mackie C, Langlois X, Schmidt ME
Profiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotyping.
EJNMMI Res. 2013;3(1):10. PubMed: 23406885PAPER Tan RH, Wong S, Hodges JR, Halliday GM, Hornberger M
Retrosplenial cortex (BA 29) volumes in behavioral variant frontotemporal dementia and Alzheimer's disease.
Dement Geriatr Cogn Disord. 2013;35(3-4):177-82. PubMed: 23406695PAPER García-Alberca JM, Lara JP, Cruz B, Garrido V, Gris E, Barbancho MÁ
Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment.
J Nerv Ment Dis. 2013 Mar;201(3):251-7. PubMed: 23407210PAPER Kerrigan TL, Randall AD
A new player in the "synaptopathy" of Alzheimer's disease- arc/arg 3.1.
Front Neurol. 2013;4:9. PubMed: 23407382PAPER Shi Q, Prior M, Zhou X, Tang X, He W, Hu X, Yan R
Preventing formation of reticulon 3 immunoreactive dystrophic neurites improves cognitive function in mice.
J Neurosci. 2013 Feb 13;33(7):3059-66. PubMed: 23407961PAPER Noetzli M, Eap CB
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.
Clin Pharmacokinet. 2013 Apr;52(4):225-41. PubMed: 23408070PAPER Jiang T, Yu JT, Zhu XC, Tan L
TREM2 in Alzheimer's disease.
Mol Neurobiol. 2013 Feb 14; PubMed: 23407992PAPER Weihl CC
Monitoring Autophagy in the Treatment of Protein Aggregate Diseases: Steps Toward Identifying Autophagic Biomarkers.
Neurotherapeutics. 2013 Feb 14; PubMed: 23408309PAPER Chitra L, Kumar CR, Basha HM, Ponne S, Boopathy R
Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment.
Proteins. 2013 Feb 14; PubMed: 23408593PAPER Beyer MK, Alves G, Hwang KS, Babakchanian S, Bronnick KS, Chou YY, Dalaker TO, Kurz MW, Larsen JP, Somme JH, Thompson PM, Tysnes OB, Apostolova LG
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease.
Mov Disord. 2013 Mar;28(3):302-10. PubMed: 23408705Current Filters
No filters selected